
In part 1 of our midterm election FAQ series, AJ Barbarito, Esq, breaks down ongoing legal developments for pharmacists and what a change in Congressional control could mean for the profession.
Drug manufacturers think too much blame related to drug errors is being heaped on drug trademarks





